Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.

E&C Panel Punts On Votes For Two Rare Disease Drug Bills

The Energy & Commerce health subcommittee failed to take a vote Thursday (May 16) on two long-discussed bills to boost rare disease drug development, likely due to pushback from the full committee’s ranking Democrat, Rep. Frank Pallone (NJ).

Inside Drug Pricing Home Page


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.